NCCN and Lilly Support Quality Improvements for Gastric Cancer Care
"We're particularly interested in projects that address gaps in clinical care through interventions that are easily scalable, reproducible, and implementable across various diverse oncology practice settings," said
There are multiple factors that contribute to the complexity of treating gastric cancer, which is also known as stomach cancer. Difficulties include managing treatment and disease-related side effects, nutritional concerns, psychological distress and anxiety, employment re-entry, and financial burden. Additionally, it's crucial to make sure patients and caregivers are provided with the resources and education needed to ensure informed, shared decision-making.
"Gastric cancer is a leading cause of cancer-related deaths globally, and Lilly is deeply committed to patients with this aggressive disease," said
The Request for Proposals (RFP) will focus on the following areas of emphasis:
1. Opportunities for innovative programs, tools, technologies and clinical pathways or platforms to improve:
- Adherence to evidence-based medicine guidelines, including, when appropriate, choosing systemic regimens based on current, best practices for the treatment of gastric/GEJ cancer.
- Collaboration between comprehensive cancer centers and community hospitals.
- Patient safety during treatment and patient adherence to treatment.
- Holistic and integrative or evidence-based complementary medicine support programs around nutrition, physical activity, psychosocial counseling, financial counseling, and other areas of need.
- Multidisciplinary collaborations within the community setting, including partnerships with businesses and foundations.
2. Opportunities to address gaps in clinical practice (including clinician, patient, healthcare system, financial, and organizational factors) through improving:
- Healthcare professional competencies (excluding requests for Continuing Medical Education grants).
- Healthcare system-based management.
- Patient oriented solutions.
- External factors that impact patient care and clinical outcomes.
The NCCN ORP — which supports scientifically meritorious research studies at NCCN Member Institutions and other cancer centers — will oversee application review and evaluation. A committee led by NCCN and including a medical representative from Lilly will determine which proposals will receive funding. Funding will be provided by Lilly.
The RFP letter-of-intent deadline is
About Lilly Oncology
For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world. To learn more about Lilly's commitment to people with cancer, please visit www.LillyOncology.com.
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and newsroom.lilly.com/social-channels.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.
The NCCN Member Institutions are: Fred &
Media Contact – NCCN
Media Contact – Lilly
Tracy J. Henrikson
View original content to download multimedia:http://www.prnewswire.com/news-releases/nccn-and-lilly-support-quality-improvements-for-gastric-cancer-care-300711118.html
SOURCE National Comprehensive Cancer Network; Lilly